In our experimental system, PD-1 blockade led to enhanced numbers of NK cells within the TME together with a measurable but not-significant reduction in tumor volume compared with mice depleted of NK1.1 cells treated with anti-PD-1. Here, PDCD1 is linked to neoplasm.